Research ExplorerPublicationsHealth economic evaluation of a web-based intervention for d...

Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study

Standard

Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. / Gräfe, Viola; Berger, Thomas; Hautzinger, Martin; Hohagen, Fritz; Lutz, Wolfgang; Meyer, Björn; Moritz, Steffen; Rose, Matthias; Schröder, Johanna; Späth, Christina; Klein, Jan Philipp; Greiner, Wolfgang.

In: HEALTH ECON REV, Vol. 9, No. 1, 07.06.2019, p. 16.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Gräfe, V, Berger, T, Hautzinger, M, Hohagen, F, Lutz, W, Meyer, B, Moritz, S, Rose, M, Schröder, J, Späth, C, Klein, JP & Greiner, W 2019, 'Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study', HEALTH ECON REV, vol. 9, no. 1, pp. 16. https://doi.org/10.1186/s13561-019-0233-y

APA

Gräfe, V., Berger, T., Hautzinger, M., Hohagen, F., Lutz, W., Meyer, B., Moritz, S., Rose, M., Schröder, J., Späth, C., Klein, J. P., & Greiner, W. (2019). Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. HEALTH ECON REV, 9(1), 16. https://doi.org/10.1186/s13561-019-0233-y

Vancouver

Gräfe V, Berger T, Hautzinger M, Hohagen F, Lutz W, Meyer B et al. Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study. HEALTH ECON REV. 2019 Jun 7;9(1):16. https://doi.org/10.1186/s13561-019-0233-y

Bibtex

@article{1fd47469dc0645698b8de797c100cc11,
title = "Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study",
abstract = "BACKGROUND: Depression often remains undiagnosed or treated inadequately. Web-based interventions for depression may improve accessibility of treatment and reduce disease-related costs. This study aimed to examine the potential of the web-based cognitive behavioral intervention {"}deprexis{"} in reducing disease-related costs.METHODS: Participants with mild to moderate depressive symptoms were recruited and randomized to either a 12-week web-based intervention (deprexis) in addition to care as usual (intervention group) or care as usual (control group). Outcome measures were health-related resource use, use of medication and incapacity to work as well as relating direct health care costs. Outcomes were assessed on patients' self-report at baseline, three months and six months.RESULTS: A total of 1013 participants were randomized. In both groups total direct health care costs decreased during the study period, but changes from baseline did not significantly differ between study groups. Numeric differences between study groups existed in outpatient treatment costs. They could be attributed to differences in changes of costs for psychotherapeutic treatment from baseline. Whereas costs for psychotherapeutic treatment decreased in the intervention group, costs increased in the control group (- 16.8% (€80) vs. + 14.7% (€60)) (tdf = 685 = 2.57; p = 0.008).CONCLUSION: The study indicates the health economic potential of innovative e-mental-health programs. There is evidence to suggest that the use of deprexis over a period of 12 weeks leads to a decrease in outpatient treatment cost, especially in those related to different types of psychotherapeutic treatment.",
author = "Viola Gr{\"a}fe and Thomas Berger and Martin Hautzinger and Fritz Hohagen and Wolfgang Lutz and Bj{\"o}rn Meyer and Steffen Moritz and Matthias Rose and Johanna Schr{\"o}der and Christina Sp{\"a}th and Klein, {Jan Philipp} and Wolfgang Greiner",
year = "2019",
month = jun,
day = "7",
doi = "10.1186/s13561-019-0233-y",
language = "English",
volume = "9",
pages = "16",
journal = "HEALTH ECON REV",
issn = "2191-1991",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

RIS

TY - JOUR

T1 - Health economic evaluation of a web-based intervention for depression: the EVIDENT-trial, a randomized controlled study

AU - Gräfe, Viola

AU - Berger, Thomas

AU - Hautzinger, Martin

AU - Hohagen, Fritz

AU - Lutz, Wolfgang

AU - Meyer, Björn

AU - Moritz, Steffen

AU - Rose, Matthias

AU - Schröder, Johanna

AU - Späth, Christina

AU - Klein, Jan Philipp

AU - Greiner, Wolfgang

PY - 2019/6/7

Y1 - 2019/6/7

N2 - BACKGROUND: Depression often remains undiagnosed or treated inadequately. Web-based interventions for depression may improve accessibility of treatment and reduce disease-related costs. This study aimed to examine the potential of the web-based cognitive behavioral intervention "deprexis" in reducing disease-related costs.METHODS: Participants with mild to moderate depressive symptoms were recruited and randomized to either a 12-week web-based intervention (deprexis) in addition to care as usual (intervention group) or care as usual (control group). Outcome measures were health-related resource use, use of medication and incapacity to work as well as relating direct health care costs. Outcomes were assessed on patients' self-report at baseline, three months and six months.RESULTS: A total of 1013 participants were randomized. In both groups total direct health care costs decreased during the study period, but changes from baseline did not significantly differ between study groups. Numeric differences between study groups existed in outpatient treatment costs. They could be attributed to differences in changes of costs for psychotherapeutic treatment from baseline. Whereas costs for psychotherapeutic treatment decreased in the intervention group, costs increased in the control group (- 16.8% (€80) vs. + 14.7% (€60)) (tdf = 685 = 2.57; p = 0.008).CONCLUSION: The study indicates the health economic potential of innovative e-mental-health programs. There is evidence to suggest that the use of deprexis over a period of 12 weeks leads to a decrease in outpatient treatment cost, especially in those related to different types of psychotherapeutic treatment.

AB - BACKGROUND: Depression often remains undiagnosed or treated inadequately. Web-based interventions for depression may improve accessibility of treatment and reduce disease-related costs. This study aimed to examine the potential of the web-based cognitive behavioral intervention "deprexis" in reducing disease-related costs.METHODS: Participants with mild to moderate depressive symptoms were recruited and randomized to either a 12-week web-based intervention (deprexis) in addition to care as usual (intervention group) or care as usual (control group). Outcome measures were health-related resource use, use of medication and incapacity to work as well as relating direct health care costs. Outcomes were assessed on patients' self-report at baseline, three months and six months.RESULTS: A total of 1013 participants were randomized. In both groups total direct health care costs decreased during the study period, but changes from baseline did not significantly differ between study groups. Numeric differences between study groups existed in outpatient treatment costs. They could be attributed to differences in changes of costs for psychotherapeutic treatment from baseline. Whereas costs for psychotherapeutic treatment decreased in the intervention group, costs increased in the control group (- 16.8% (€80) vs. + 14.7% (€60)) (tdf = 685 = 2.57; p = 0.008).CONCLUSION: The study indicates the health economic potential of innovative e-mental-health programs. There is evidence to suggest that the use of deprexis over a period of 12 weeks leads to a decrease in outpatient treatment cost, especially in those related to different types of psychotherapeutic treatment.

U2 - 10.1186/s13561-019-0233-y

DO - 10.1186/s13561-019-0233-y

M3 - SCORING: Journal article

C2 - 31175475

VL - 9

SP - 16

JO - HEALTH ECON REV

JF - HEALTH ECON REV

SN - 2191-1991

IS - 1

ER -